Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1175689-23-2

Post Buying Request

1175689-23-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1175689-23-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1175689-23-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,5,6,8 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1175689-23:
(9*1)+(8*1)+(7*7)+(6*5)+(5*6)+(4*8)+(3*9)+(2*2)+(1*3)=192
192 % 10 = 2
So 1175689-23-2 is a valid CAS Registry Number.

1175689-23-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(4-Methylpiperazin-1-yl)pyridine-2-carbonitrile

1.2 Other means of identification

Product number -
Other names 6-(4-methyl-1-piperazinyl)-3-pyridinecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1175689-23-2 SDS

1175689-23-2Downstream Products

1175689-23-2Relevant articles and documents

PYRAZINE COMPOUNDS AND USES THEREOF

-

Page/Page column 206, (2020/03/05)

The present disclosure novel pyrazine compounds targeting adenosine receptors (especially A1 and A2, particularly A2a). The present disclosure also relates to pharmaceutical compositions comprising one or more of the compounds as an active ingredient, and use of the compounds in the treatment of adenosine receptor (AR) associated diseases, for example cancer such as NSCLC, RCC, prostate cancer, and breast cancer.

Pyridinyl Amides for the Treatment of CNS and Metabolic Disorders

-

Page/Page column 17, (2009/08/16)

The present invention relates to novel pyridinyl derivatives of Formula wherein Y, Z, L, R1 through R11, n, m, p, q, t are as defined herein, that are 5-HT receptor ligands, particularly the 5-HT6 subtype, and as such are useful for

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1175689-23-2